SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-189260
Filing Date
2019-07-03
Accepted
2019-07-03 16:34:03
Documents
4
Period of Report
2019-06-26
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d763414d8k.htm 8-K 33882
2 EX-3.1 d763414dex31.htm EX-3.1 25069
3 EX-3.2 d763414dex32.htm EX-3.2 101226
4 EX-4.1 d763414dex41.htm EX-4.1 121495
  Complete submission text file 0001193125-19-189260.txt   282917
Mailing Address 421 KIPLING STREET PALO ALTO CA 94301
Business Address 421 KIPLING STREET PALO ALTO CA 94301 (650) 391-9740
BridgeBio Pharma, Inc. (Filer) CIK: 0001743881 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38959 | Film No.: 19942307
SIC: 2834 Pharmaceutical Preparations